Skip to main content

Table 2 Left ventricular end-diastolic diameter across categories of 18FDG uptake at each 18FDG-PET scan

From: An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline

 

LV-SUV

LVEDD (mm)

P

PETSTAGING

Low

47.3 ± 5.2

0.81

High

47.7 ± 5.2

PETINTERIM

Low

46.1 ± 4..9

0.11

High

48.7 ± 5.2

PETEOT

Low

47.7 ± 4.8

0.90

High

47.7 ± 5.1

  1. Left ventricular end-diastolic diameter (LVEDD), as assessed by echocardiography performed after completion of anthracycline chemotherapy, in patients with myocardial 18FDG standardized uptake values (LV-SUV) below or above the median value (low and high, respectively) measured at each 18FDG positron emission tomography (18FDG-PET) scan
  2. For each PET time point, LVEDD was compared between patients with LV-SUV below vs. above the median value by unpaired t-test
  3. LV-SUVSTAGING: LV-SUV at the 18FDG-PET scan before treatment; LV-SUVINTERIM: LV-SUV at the 18FDG-PET performed after 2 cycles of doxorubicin; LV-SUVEOT: LV-SUV at the 18FDG-PET performed at the end of chemotherapy
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us